Dinesh V Ph D Patel is President and CEO of Protagonist Therapeutics, Inc. Currently has a direct ownership of 564,260 shares of PTGX, which is worth approximately $27.6 Million. The most recent transaction as insider was on Apr 26, 2022, when has been sold 30,000 shares (Common Stock) at a price of $4.21 per share, resulting in proceeds of $126,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 564K
1.08% 3M change
2.67% 12M change
Total Value Held $27.6 Million

DINESH V PH D PATEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 26 2022
BUY
Exercise of conversion of derivative security
$126,300 $4.21 p/Share
30,000 Added 5.01%
568,306 Common Stock
Apr 14 2022
BUY
Exercise of conversion of derivative security
$64,424 $1.89 p/Share
34,087 Added 5.96%
537,847 Common Stock
Feb 28 2022
SELL
Payment of exercise price or tax liability
$112,853 $24.28 p/Share
4,648 Reduced 0.91%
503,760 Common Stock
Feb 15 2022
BUY
Grant, award, or other acquisition
-
31,250 Added 5.79%
508,408 Common Stock
Dec 21 2021
SELL
Open market or private sale
$482,100 $32.14 p/Share
15,000 Reduced 3.05%
477,158 Common Stock
Sep 21 2021
BUY
Exercise of conversion of derivative security
$168,400 $4.21 p/Share
40,000 Added 7.52%
492,158 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
-
25,000 Added 5.25%
451,144 Common Stock
Jan 19 2021
SELL
Open market or private sale
$611,212 $24.6 p/Share
24,846 Reduced 5.51%
426,144 Common Stock
Jan 19 2021
BUY
Exercise of conversion of derivative security
$54,730 $4.21 p/Share
13,000 Added 2.8%
450,990 Common Stock
DVP

Dinesh V Ph D Patel

President and CEO
Newark, CA

Track Institutional and Insider Activities on PTGX

Follow Protagonist Therapeutics, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTGX shares.

Notify only if

Insider Trading

Get notified when an Protagonist Therapeutics, Inc insider buys or sells PTGX shares.

Notify only if

News

Receive news related to Protagonist Therapeutics, Inc

Track Activities on PTGX